Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Virgin Wines UK (VINO) by Steve Moore in ShareProphets
- Hold SEGRO (SGRO) by Jefferies
- Avoid Pennant International Group (PEN) by Steve Moore in ShareProphets
- Buy CMC Markets (CMCX) by Paul Summers in The Motley Fool
- Buy AstraZeneca (AZN) by LBBW
- Watch Empresaria Group (EMR) by Steve Moore in ShareProphets
- Buy Centamin (DI) (CEY) by Nigel Somerville in ShareProphets
- Neutral Ryanair Holdings (CDI) (0RYA) by UBS
- Buy Relx plc (REL) by UBS
- Sell Unilever (ULVR) by UBS
- Hold AstraZeneca (AZN) by DZ Bank
- Buy British American Tobacco (BATS) by Deutsche Bank
- Hold Hammerson (HMSO) by Deutsche Bank
- Buy Computacenter (CCC) by Jefferies
- Buy Man Group (EMG) by Goldman Sachs
- Sell Deliveroo Class (ROO) by Redburn
- Buy Unilever (ULVR) by Deutsche Bank
- Buy 3i Group (III) by Lauren Almeida in The Times - Tempus
- Overweight BT Group (BT.A) by Barclays
- Overweight IG Group Holdings (IGG) by Barclays
Physiomics (PYC) Share Price
Health Care Sector
NOTE: This is based on 16 open tips for Physiomics (PYC)
| Latest Bid : 0.70p | Latest Ask : 0.75p |
| High Today : 0.74p | Low Today : 0.68p |
| This Years High : 2.75p | This Years Low : 0.65p |
| Volume : 768,645 | MKT Cap : £1.46M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000
Physiomics (PYC) Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.Physiomics (PYC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | -20.83% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 39.58% |
| Sell | Tom Winnifrith | Premium Only | 2024-03-07 16:20:00 07/03/2024 | 44.23% |
| Avoid | Steve Moore | Premium Only | 2023-11-10 13:55:00 10/11/2023 | 51.67% |
| Avoid | Steve Moore | Premium Only | 2023-09-01 16:10:00 01/09/2023 | 54.69% |
Physiomics (PYC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.70p | Latest Ask : 0.75p |
| High Today : 0.74p | Low Today : 0.68p |
| This Years High : 2.75p | This Years Low : 0.65p |
| Volume : 768,645 | MKT Cap : £1.46M |
Physiomics Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Physiomics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | -20.83% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 39.58% |
| Sell | Tom Winnifrith | Premium Only | 2024-03-07 16:20:00 07/03/2024 | 44.23% |
| Avoid | Steve Moore | Premium Only | 2023-11-10 13:55:00 10/11/2023 | 51.67% |
| Avoid | Steve Moore | Premium Only | 2023-09-01 16:10:00 01/09/2023 | 54.69% |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000